Spirodela (duckweed) as an alternative production system for pharmaceuticals: a case study, aprotinin

[1]  James B. Hicks,et al.  A plant DNA minipreparation: Version II , 1983, Plant Molecular Biology Reporter.

[2]  David Passmore,et al.  Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor , 2006, Nature Biotechnology.

[3]  V. Molle,et al.  Characterization of the phosphorylation sites of Mycobacterium tuberculosis serine/threonine protein kinases, PknA, PknD, PknE, and PknH by mass spectrometry , 2006, Proteomics.

[4]  Gang Wu,et al.  The Synthetic Gene Designer: a flexible web platform to explore sequence manipulation for heterologous expression. , 2006, Protein expression and purification.

[5]  R. Twyman,et al.  Plant-derived pharmaceuticals--the road forward. , 2005, Trends in plant science.

[6]  Jan-Peter Nap,et al.  pBINPLUS: An improved plant transformation vector based on pBIN19 , 1995, Transgenic Research.

[7]  A. Stomp.  The duckweeds: a valuable plant for biomanufacturing. , 2005, Biotechnology annual review.

[8]  J. Peters,et al.  Expression, Purification, Biochemical and Pharmacological Characterization of a Recombinant Aprotinin Variant , 2004, Arzneimittelforschung.

[9]  M. Jansen,et al.  A novel stress‐acclimation response in Spirodela punctata (Lemnaceae): 2,4,6‐trichlorophenol triggers an increase in the level of an extracellular peroxidase, capable of the oxidative dechlorination of this xenobiotic pollutant , 2004 .

[10]  Rainer Fischer,et al.  Plant-based production of biopharmaceuticals. , 2004, Current opinion in plant biology.

[11]  M. Edelman,et al.  Callus induction and regeneration in Spirodela and Lemna , 2004, Plant Cell Reports.

[12]  E. Hood.  Commentary on Fischer/Emans' review , 2000, Transgenic Research.

[13]  G. Zhong,et al.  Commercial production of aprotinin in transgenic maize seeds , 1999, Molecular Breeding.

[14]  J. Gasdaska,et al.  Advantages of Therapeutic Protein Production in the Aquatic Plant Lemna , 2003 .

[15]  B. Wiggins,et al.  Production of Aprotinin in Transgenic Maize Seeds for the Pharmaceutical and Cell Culture Markets , 2003 .

[16]  R. Reeves,et al.  Combined use of regulatory elements within the cDNA to increase the production of a soluble mouse single-chain antibody, scFv, from tobacco cell suspension cultures. , 2002, Protein expression and purification.

[17]  M. Davies,et al.  Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations. , 1997, The Annals of thoracic surgery.

[18]  J. Kyhse-Andersen.  Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. , 1984, Journal of biochemical and biophysical methods.

[19]  I. Kato,et al.  Protein inhibitors of proteinases. , 1980, Annual review of biochemistry.

[20]  R. U. Schenk,et al.  Medium and techniques for induction and growth of monocotyledonous and dicotyledonous plant cell cultures , 1972 .